Related Experiment Video
Updated: Jan 26, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Abstract:
Potent MCL1 inhibitors are showing strong anticancer activity in preclinical models of hematologic cancers, especially when given in combination with other therapies. The drugs are now in phase I testing, with initial clinical results expected soon.
Insights
Potent MCL1 inhibitors demonstrate significant anticancer effects in preclinical hematologic cancer models. These promising drugs are advancing to phase I clinical trials, with early results anticipated shortly.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Myeloid cell leukemia 1 (MCL1) is a key anti-apoptotic protein implicated in various hematologic malignancies.
- Targeting MCL1 offers a promising therapeutic strategy for overcoming treatment resistance in blood cancers.
Discussion:
- Preclinical studies highlight the potent anticancer activity of MCL1 inhibitors, particularly in combination regimens.
- These inhibitors show efficacy in diverse hematologic cancer models, suggesting broad applicability.
Key Insights:
- MCL1 inhibitors exhibit strong preclinical efficacy against hematologic cancers.
- Combination therapy involving MCL1 inhibitors enhances anticancer effects.
Outlook:
- MCL1 inhibitors are currently undergoing phase I clinical trials.
- Upcoming clinical results are expected to provide crucial insights into their therapeutic potential and safety in patients.
Related Concept Videos
Aims Of Nursing
Apoptosis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Persuasion Strategies

